Inventor · disambiguated record
Anton Simeonov
Also filed as: SIMEONOV ANTON · SIMEONOV ANTON M · SIMEONOV ANTON MOMTCHILOV
21 granted patents·13 pending applications·32 citations·filing 2002–2024
92Inventor score
Files withUS HEALTH12BETH ISRAEL DEACONESS MEDICAL CT INC3EASTERN VIRGINIA MEDICAL SCHOOL3ARNER ELIAS SET JENOE2CALIPER LIFE SCIENCES INC1
Top patents by PatentIndex Score
34 records- 0194US11247971B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2021·Granted Feb 15, 2022·3 cites·17 claims
- 0290US10961200B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofTHE US SECRETARY DEPARTMENT OF HEALTH·Filed 2019·Granted Mar 30, 2021·4 cites·18 claims
- 0389US10351532B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUNIV VANDERBILT·Filed 2015·Granted Jul 16, 2019·8 cites·21 claims
- 0486US12365653B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2024·Granted Jul 22, 2025·0 cites·12 claims
- 0585US10899710B2Pyridines and their use in the treatment of cancerUS HEALTH·Filed 2016·Granted Jan 26, 2021·4 cites·20 claims
- 0684US10266488B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2014·Granted Apr 23, 2019·3 cites·9 claims
- 0781US11274077B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2020·Granted Mar 15, 2022·1 cites·20 claims
- 0879US9802904B2Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereofUS HEALTH·Filed 2013·Granted Oct 31, 2017·4 cites·4 claims
- 0977US10752581B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2019·Granted Aug 25, 2020·1 cites·13 claims
- 1076US11897845B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2022·Granted Feb 13, 2024·0 cites·19 claims
- 1174US10413548B2Methods and compositions for the inhibition of Pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Sep 17, 2019·1 cites·3 claims
- 1273US10954228B21 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereofNAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Mar 23, 2021·2 cites·18 claims
- 1370US9730941B2Methods and compositions for the inhibition of Pin1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2013·Granted Aug 15, 2017·1 cites·3 claims
- 1465US11795177B2Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitorsUS HEALTH·Filed 2022·Granted Oct 24, 2023·0 cites·22 claims
- 1562US11129835B2Methods and compositions for the inhibition of PIN1BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Sep 28, 2021·0 cites·4 claims
- 1658US2023220334A1Differentiation of trophectoderm lineage cells from pluripotent stem cellsTHE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN S·Filed 2021·Application pending·0 cites
- 1756US2023056533A1Radial Glia and Astrocyte Differentiation From Human Pluripotent Stem CellsTHE UNITED STATES O FAMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2021·Application pending·0 cites
- 1856US2025130234A1Methods and systems for analyzing target engagement data from biological assaysUS HEALTH·Filed 2022·Application pending·0 cites
- 1956US2024401239A1Synthetic humanized llama nanobody library and use thereof to identify sars-cov-2 neutralizing antibodiesUS HEALTH·Filed 2022·Application pending·0 cites
- 2054US11505559B2Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitorsUS HEALTH·Filed 2018·Granted Nov 22, 2022·0 cites·18 claims
- 2154US2022228111A1Nociceptor differentiation from human pluripotent stem cellsSINGEC ILYAS·Filed 2020·Application pending·0 cites
- 2254US2023257756A1Real-time cellular thermal shift assay (rt-cetsa) for research and drug discoveryUS HEALTH·Filed 2021·Application pending·0 cites
- 2353US2024002350A1Protein and lipid therapeutic targetsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 2453US2021348119A1Compositions and methods for cell cultureTHE US SECRETARY OF THE DEPARTMEN OF HEALTH AND HUMAN·Filed 2019·Application pending·0 cites
- 2550US2002197630A1Systems and methods for high throughput genetic analysisFiled 2002·Application pending·0 cites
- 2650US2011207784A1Oxadiazole-2-oxides as antischistosomal agentsUS HEALTH·Filed 2009·Application pending·0 cites
- 2746US10836759B2Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancerUS HEALTH·Filed 2017·Granted Nov 17, 2020·0 cites·20 claims
- 2845US2006211055A1Capture and release assay system and methodCALIPER LIFE SCIENCES INC·Filed 2006·Application pending·0 cites
- 2935US2013096159A1Inhibitors of human 12-lipoxygenaseMALONEY DAVID J·Filed 2011·Application pending·0 cites
- 3034US10881653B2Tricyclic compounds and their use in the treatment of cancerARNER ELIAS SET JENOE·Filed 2016·Granted Jan 5, 2021·0 cites·18 claims
- 3133US2020165257A1Inhibitors of phosphoinositide 3-kinase and histone deacetylase for treatment of cancerTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2018·Application pending·0 cites
- 3232US10287279B2Inhibitors of human 12/15-lipoxygenaseMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted May 14, 2019·0 cites·19 claims
- 3331US10703746B2Mutant IDH1 inhibitors useful for treating cancerTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2015·Granted Jul 7, 2020·0 cites·12 claims
- 3428US11110089B2Pyridazinones and their use in the treatment of cancerARNER ELIAS SET JENOE·Filed 2016·Granted Sep 7, 2021·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →